Milestone Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +25.0% | +280.0% | +155.3% | +273.2% | -75.4% | +3.4% | +14.1% | +8.6% | |
| – | +233.2% | +88.2% | +315.2% | +47.2% | +24.3% | +5.4% | -39.4% | +29.2% | |
| – | +233.2% | +56.9% | +369.9% | +56.0% | – | – | – | – | |
| – | – | +90.4% | -303.9% | – | -301.4% | – | +194.1% | -26.6% | |
| – | -86.1% | +8,160.0% | -76.5% | -100.0% | – | -58.8% | -70.5% | +815.2% | |
| – | – | -102.4% | +18,129.2% | – | -181.6% | – | +74.2% | +35.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +159.4% | +6.1% | -43.3% | -99.8% | – | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | |
| – | +160.8% | +6.6% | -14.3% | -93.1% | -38.9% | +1,447.7% | -32.8% | +166.3% | |
| – | +1,029.3% | -54.9% | -240.3% | – | -354.6% | – | +88.7% | +313.1% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.